Page last updated: 2024-10-31

nabumetone and Osteonecrosis

nabumetone has been researched along with Osteonecrosis in 1 studies

Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.

Osteonecrosis: Death of a bone or part of a bone, either atraumatic or posttraumatic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ike, RW1
Bole, GG1

Other Studies

1 other study available for nabumetone and Osteonecrosis

ArticleYear
Pseudoseptic arthritis due to acute lipoarthrosis in a systemic lupus erythematosus patient with osteonecrosis.
    Arthritis and rheumatism, 2009, Aug-15, Volume: 61, Issue:8

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Infectious; Butanones; Diagnosis, Differen

2009